有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 4-Ethyl-3-[(4-fluorophenyl)methylsulfanyl]-5-propyl-1,2,4-triazole | —— | C14H18FN3S |
|
—— | 3-Benzylsulfanyl-4-ethyl-5-propyl-1,2,4-triazole | —— | C14H19N3S |
|
—— | 2-Benzylsulfanyl-5-ethyl-1,3,4-oxadiazole | —— | C11H12N2OS |
|
—— | 2-[(4-Ethyl-5-propyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-methyl-1,3,4-oxadiazole | —— | C11H17N5OS |
|
—— | 2-[(5-methyl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-5-propyl-1,3,4-oxadiazole | —— | C9H13N5OS |
|
—— | 2-[(5-Benzyl-4-ethyl-1,2,4-triazol-3-yl)sulfanylmethyl]-5-propyl-1,3,4-oxadiazole | —— | C17H21N5OS |
|
—— | 2-Ethyl-5-[(5-propyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C10H14N4O2S |
|
—— | 2-Methyl-5-[(5-methyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C7H8N4O2S |
|
—— | 2-Propyl-5-[(5-propyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C11H16N4O2S |
|
—— | 2-{[(5-ethyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl}-5-phenyl-1,3,4-oxadiazole | —— | C13H13N5OS |
|
—— | 2-[(5-benzyl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-5-phenyl-1,3,4-oxadiazole | —— | C18H15N5OS |
|
—— | 2-[(5-ethyl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-5-methyl-1,3,4-oxadiazole | —— | C8H11N5OS |
|
—— | 2-Methyl-5-[(5-propyl-1,3,4-oxadiazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazole | —— | C9H12N4O2S |
|
—— | (2R)-2-(4-bromophenyl)sulfanyl-N-[2-(4-fluorophenyl)ethyl]propanamide | —— | C17H17BrFNOS |
|
—— | N'-acetyl-2-(4-bromophenyl)sulfanylacetohydrazide | —— | C10H11BrN2O2S |
|
—— | N-[3-[(2-chlorophenyl)methyl]-1,3-thiazol-2-ylidene]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H12ClN5OS2 |
|
—— | 1-[2,5-dimethyl-1-(1,3-thiazol-2-yl)pyrrol-3-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C13H13N5OS2 |
|
—— | 1-(5-chlorothiophen-2-yl)-2-(4H-1,2,4-triazol-3-ylsulfanyl)ethanone | —— | C8H6ClN3OS2 |
|
—— | (2S)-2-(4-bromophenyl)sulfanyl-N-[2-(4-fluorophenyl)ethyl]propanamide | —— | C17H17BrFNOS |
|
—— | methyl 2,4-dimethyl-5-[(2R)-2-(1H-1,2,4-triazol-5-ylsulfanyl)propanoyl]-1H-pyrrole-3-carboxylate | —— | C13H16N4O3S |
|
—— | 1-(5-bromothiophen-2-yl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C8H6BrN3OS2 |
|
—— | 2-(4-bromophenyl)sulfanyl-N-[(3R)-3-methyl-1,1-dioxothiolan-3-yl]acetamide | —— | C13H16BrNO3S2 |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[(4R)-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl]prop-2-enoate | —— | C16H13N4O4S- |
|
—— | 2-(4-bromophenyl)sulfanyl-N-[(3S)-3-methyl-1,1-dioxothiolan-3-yl]acetamide | —— | C13H16BrNO3S2 |
|
—— | 1-(5-phenyl-3,4-dihydropyrazol-2-yl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C13H13N5OS |
|
—— | N-[4-(3,4-dimethylphenyl)sulfanylphenyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C18H18N4OS2 |
|
—— | (E)-3-[5-(azepan-1-yl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C16H18N3O4S- |
|
—— | 2-[(4-Bromophenyl)sulfanylmethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C13H9BrN2OS2 |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[(4R)-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl]prop-2-enoic acid | —— | C16H14N4O4S |
|
—— | (E)-3-[5-(3-bromophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C16H10BrN2O4S- |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-phenylsulfanylfuran-2-yl)prop-2-enoate | —— | C16H11N2O4S2- |
|
—— | N-[(4-chlorophenyl)methyl]-N-methyl-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H13ClN4OS |
|
—— | (E)-3-[5-(diethylamino)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C14H17N3O4S |
|
—— | (E)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-morpholin-4-ylfuran-2-yl)prop-2-enoic acid | —— | C14H15N3O5S |
|
—— | 1-[(3R)-3-(furan-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C18H17N5O2S |
|
—— | (Z)-3-[4-bromo-5-(dimethylamino)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C12H11BrN3O4S- |
|
—— | (Z)-3-(4-bromo-5-piperidin-1-ylfuran-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C15H15BrN3O4S- |
|
—— | 1-[1-[(2R)-1-methoxypropan-2-yl]-2,5-dimethylpyrrol-3-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C14H20N4O2S |
|
—— | (Z)-3-[4-bromo-5-(dimethylamino)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C12H12BrN3O4S |
|
—— | (E)-3-[5-(diethylamino)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C14H16N3O4S- |
|
—— | (E)-3-(5-methylfuran-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C11H10N2O4S |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)propanamide | —— | C12H17N5OS |
|
—— | (Z)-3-(5-bromothiophen-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C10H6BrN2O3S2- |
|
—— | (Z)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[5-(4-methylphenyl)sulfanylfuran-2-yl]prop-2-enoic acid | —— | C17H14N2O4S2 |
|
—— | N-[(2R)-4-phenylbutan-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H18N4OS |
|
—— | (Z)-3-(4-bromo-5-piperidin-1-ylfuran-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C15H16BrN3O4S |
|
—— | (E)-3-(furan-2-yl)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C10H7N2O4S- |
|
—— | N-[(2R)-2-cyano-3-methylbutan-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C10H15N5OS |
|
—— | (E)-3-[5-(3-bromophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C16H11BrN2O4S |
|
—— | (2S)-N-cyclopentyl-2-(1H-1,2,4-triazol-5-ylsulfanyl)propanamide | —— | C10H16N4OS |
|